Product Code: MCD494K
As therapeutic drug markets continue to evolve, advancements in drugs and devices are producing several positive improvements. New formulations are extending drug release profiles, leading to less frequent dosing. Enhancements in syringe and injector usability are increasing the number and types of therapeutics that can be self-administered. These advances have revealed a new set of concerns. Weekly, bi-weekly and monthly dosing deprives the patient of the repetitive reinforcement that is a key tenet of self-injection safety at a time when the dangers associated with powerful drug side effects are placing a priority on the need for accurate dosing and delivery. In response, device suppliers have been developing syringes and injectors with new technology, adding capabilities that address self-administration safety concerns. Using innovative technical solutions, these device features decrease patient reliance on recall, guiding them through the medication process and reducing the risk of drug dosing errors.
Microchip Controlled Subcutaneous Drug Delivery Devices - What You Will Learn
- What SC injection devices rely on microprocessors to control the three stages of injection, what are the device specifics, and who markets them?
- What are the essential design factors for microchip controlled subcutaneous injection devices, what are the enabling technologies, and what are the performance criteria?
- What is the size of the market today, who are the market share leaders, and what will the market share be in 2024?
- What are the therapeutic applications for microchip controlled injectors, who are the developers, and what indications are they targeting?
- What are the market drivers for microchip controlled subcutaneous drug delivery devices?
- What are the significant economic, technology, and regulatory factors affecting the market?
Table of Contents
Microchip Controlled Drug Delivery
- Devices and Technologies
- Market Segments and Indications
- Demographics and Growth
- Market Drivers
- Risk Factors
Microchip Injection Device Design Factors
- Chip Technology
- Data Collection & Transfer
- Data Interface
Microchip Controlled Injector Features & Capabilities
- EMR Integration
- Injection Event Time Stamp
- Needle Injection Depth & Speed
- Power Management
- Remote Monitoring
- Variable Dose Capture
- Wireless Data Transfer
Microchip Controlled Injection Device Commercial Analysis
- Handheld Devices
- Single Use
- Needle-free Injectors
- Pen Injectors
- Wearable Devices
- Development-stage Devices
Microchip Device Therapeutics, Applications & Market Data
- Autoimmune Diseases
- Metabolic Diseases